132 related articles for article (PubMed ID: 1499075)
1. [The antitumor effects of tumor-infiltrating lymphocytes (TIL) being proliferated in vitro].
Zhang BX
Zhonghua Bing Li Xue Za Zhi; 1992 Apr; 21(2):79-81. PubMed ID: 1499075
[TBL] [Abstract][Full Text] [Related]
2. [Observation on the phenotypic changes of tumor-infiltrating lymphocytes(TIL) during cultivation in vitro].
Zhang BX
Zhonghua Bing Li Xue Za Zhi; 1992 Oct; 21(5):281-3. PubMed ID: 1291150
[TBL] [Abstract][Full Text] [Related]
3. Phenotypical and functional differences of tumor-infiltrating lymphocytes from human colorectal cancers induced by costimulation with rIL-2 and rIL-4 in vitro.
Keller H; Wimmenauer S; Rahner S; Von Kleist S; Farthmann EH
Anticancer Res; 1996; 16(6B):3565-70. PubMed ID: 9042222
[TBL] [Abstract][Full Text] [Related]
4. Large-scale expansion in interleukin-2 of tumor-infiltrating lymphocytes from patients with ovarian carcinoma for adoptive immunotherapy.
Freedman RS; Tomasovic B; Templin S; Atkinson EN; Kudelka A; Edwards CL; Platsoucas CD
J Immunol Methods; 1994 Jan; 167(1-2):145-60. PubMed ID: 8308273
[TBL] [Abstract][Full Text] [Related]
5. Efficacy of tumor-infiltrating lymphocytes in the treatment of hepatic metastases arising from transgenic intraocular tumors in mice.
Ma D; Niederkorn JY
Invest Ophthalmol Vis Sci; 1995 May; 36(6):1067-75. PubMed ID: 7730016
[TBL] [Abstract][Full Text] [Related]
6. Induction of antitumor activity and experimental expansion of human lung cancer-infiltrating lymphocytes.
Xu Z; Shao J; Zhang Y; Li D; Li Y; Ba D
Chin Med Sci J; 1991 Jun; 6(2):87-91. PubMed ID: 1804382
[TBL] [Abstract][Full Text] [Related]
7. Morphological and functional characteristics of tumor-infiltrating lymphocytes from human colorectal cancers after stimulation with rIL-2.
Keller H; Wimmenauer S; Rahner S; Reimer P; von Kleist S; Farthmann EH
Eur Surg Res; 1995; 27(4):258-68. PubMed ID: 7649213
[TBL] [Abstract][Full Text] [Related]
8. Clinical results and characterization of tumor-infiltrating lymphocytes with or without recombinant interleukin 2 in human metastatic renal cell carcinoma.
Bukowski RM; Sharfman W; Murthy S; Rayman P; Tubbs R; Alexander J; Budd GT; Sergi JS; Bauer L; Gibson V
Cancer Res; 1991 Aug; 51(16):4199-205. PubMed ID: 1868441
[TBL] [Abstract][Full Text] [Related]
9. The therapeutic efficacy of murine anti-tumor T cells: freshly isolated T cells are more therapeutic than T cells expanded in vitro.
Evans R; Kamdar SJ; Duffy TM; Krupke DM; Fuller JA; Dudley ME
Anticancer Res; 1995; 15(2):441-7. PubMed ID: 7763019
[TBL] [Abstract][Full Text] [Related]
10. Successful adoptive cellular immunotherapy is dependent on induction of a host immune response triggered by cytokine (IFN-gamma and granulocyte/macrophage colony-stimulating factor) producing donor tumor-infiltrating lymphocytes.
Nagoshi M; Goedegebuure PS; Burger UL; Sadanaga N; Chang MP; Eberlein TJ
J Immunol; 1998 Jan; 160(1):334-44. PubMed ID: 9551989
[TBL] [Abstract][Full Text] [Related]
11. [Combined antitumor effect of tumor-infiltrating lymphocytes and tumor necrosis factor alpha].
Yin C; Zhang B; Zheng J
Zhonghua Bing Li Xue Za Zhi; 1995 Jun; 24(3):162-4. PubMed ID: 7656383
[TBL] [Abstract][Full Text] [Related]
12. Proliferative, phenotypic and functional and molecular characteristics of tumour-infiltrating lymphocytes obtained from unselected patients with malignant melanomas and expanded in vitro in the presence of recombinant interleukin-2.
Melioli G; Guastella M; Semino C; Meta M; Pietra G; Ponte M; Queirolo P; Sertoli MR; Martini L; Reali UM
Melanoma Res; 1994 Apr; 4(2):127-33. PubMed ID: 8069098
[TBL] [Abstract][Full Text] [Related]
13. Recruitment of host CD8+ T cells by tumor-infiltrating lymphocytes and recombinant interleukin-2 during adoptive immunotherapy of cancer.
Burger UL; Chang MP; Goedegebuure PS; Eberlein TJ; Adams-Hodgins S
Surgery; 1995 Mar; 117(3):325-33. PubMed ID: 7878540
[TBL] [Abstract][Full Text] [Related]
14. The use of interleukin-6 to generate tumor-infiltrating lymphocytes with enhanced in vivo antitumor activity.
Marcus SG; Perry-Lalley D; Mulé JJ; Rosenberg SA; Yang JC
J Immunother Emphasis Tumor Immunol; 1994 Feb; 15(2):105-12. PubMed ID: 8136942
[TBL] [Abstract][Full Text] [Related]
15. Production and characterization of tumor infiltrating lymphocyte clones derived from B16-F10 murine melanoma.
Maeda K; Lafreniere R; Jerry LM
J Invest Dermatol; 1991 Aug; 97(2):183-9. PubMed ID: 2071934
[TBL] [Abstract][Full Text] [Related]
16. MART-1-specific melanoma tumor-infiltrating lymphocytes maintaining CD28 expression have improved survival and expansion capability following antigenic restimulation in vitro.
Li Y; Liu S; Hernandez J; Vence L; Hwu P; Radvanyi L
J Immunol; 2010 Jan; 184(1):452-65. PubMed ID: 19949105
[TBL] [Abstract][Full Text] [Related]
17. Clinical and biological effects of intraperitoneal injections of recombinant interferon-gamma and recombinant interleukin 2 with or without tumor-infiltrating lymphocytes in patients with ovarian or peritoneal carcinoma.
Freedman RS; Kudelka AP; Kavanagh JJ; Verschraegen C; Edwards CL; Nash M; Levy L; Atkinson EN; Zhang HZ; Melichar B; Patenia R; Templin S; Scott W; Platsoucas CD
Clin Cancer Res; 2000 Jun; 6(6):2268-78. PubMed ID: 10873077
[TBL] [Abstract][Full Text] [Related]
18. Large scale expansion of human tumor infiltrating lymphocytes with surface-modified stimulator cells for adoptive immunotherapy.
Chin Y; Janssens J; Smeyers E; Bleus J; Zhang J; Raus J
Anticancer Res; 1992; 12(3):733-6. PubMed ID: 1622131
[TBL] [Abstract][Full Text] [Related]
19. Transduction of rIL-2 expanded CD4+ and CD8+ ovarian TIL-derived T cell lines with the G1Na (neor) replication-deficient retroviral vector.
Nash MA; Platsoucas CD; Wong BY; Wong PM; Cottler-Fox M; Otto E; Freedman RS
Hum Gene Ther; 1995 Nov; 6(11):1379-89. PubMed ID: 8573611
[TBL] [Abstract][Full Text] [Related]
20. Characterization of human tumor-infiltrating lymphocytes expanded in hollow-fiber bioreactors for immunotherapy of cancer.
Malone CC; Schiltz PM; Mackintosh AD; Beutel LD; Heinemann FS; Dillman RO
Cancer Biother Radiopharm; 2001 Oct; 16(5):381-90. PubMed ID: 11776755
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]